← All companies

SGP

SpyGlass Pharma, Inc.

SGP Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$22.68

-0.04 -0.18%

Key statistics

from XBRL data in SEC filings

Market cap

$758M

Revenue (TTM)

—

Net income (TTM)

-$39.9M

EPS (TTM)

$-17.98

P/E ratio

—

Dividend yield

—

Free cash flow

-$33.5M

Cash

$239M

Total assets

$258M

Gross margin

—

52-week range

$17.06 – $32.44

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Other events Mar 9, 2026 8-K Director or officer change Feb 13, 2026 8-K Director or officer change; Amended charter or bylaws; Regulation FD disclosure Feb 9, 2026

Other filings

SCHEDULE 13G Feb 17, 2026 SCHEDULE 13D Feb 17, 2026 SCHEDULE 13D Feb 13, 2026 SCHEDULE 13D Feb 13, 2026 SCHEDULE 13G Feb 13, 2026 4 Feb 11, 2026 4/A Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 SCHEDULE 13D Feb 10, 2026 4 Feb 10, 2026 4 Feb 10, 2026 4 Feb 9, 2026 4 Feb 9, 2026 4 Feb 9, 2026 4 Feb 9, 2026 4 Feb 9, 2026 4 Feb 9, 2026 4 Feb 9, 2026 4 Feb 9, 2026 4 Feb 9, 2026 4 Feb 9, 2026 4 Feb 9, 2026